연구동향 분석
박사

Bordetella pertussis 섬모 내 인플루엔자 바이러스 당단백질의 이종항원 발현 및 면역효과 : Heterologous expression of influenza virus glycoprotein in Bordetella pertussis fimbriae and its immunologic effect

서자영 2015년

논문상세정보
인용/피인용
' Bordetella pertussis 섬모 내 인플루엔자 바이러스 당단백질의 이종항원 발현 및 면역효과 : Heterologous expression of influenza virus glycoprotein in Bordetella pertussis fimbriae and its immunologic effect' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • bordetella pertussis
  • glycoprotein
  • heterologous expression
  • homologous recombination
  • influenza virus
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
87 0

0.0%

' Bordetella pertussis 섬모 내 인플루엔자 바이러스 당단백질의 이종항원 발현 및 면역효과 : Heterologous expression of influenza virus glycoprotein in Bordetella pertussis fimbriae and its immunologic effect' 의 참고문헌

  • van den Berg BM, Beekhuizen H, Willems RJ, Mooi FR, van Furth R. Role of Bordetella pertussis virulence factors in adherence to epithelial cell lines derived from the human respiratory tract. Infect Immun 1999 ;67:1056-62.
  • Zepp F, Heininger U, Mertsola J, Bernatowska E, Guiso N, Roord J, et al. Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect Dis 2011;11:557-70.
  • Yu X, Jacobs SA, West SC, Ogawa T, Egelman EH. Domain structure and dynamics in the helical filaments formed by RecA and Rad51 on DNA. PNAS 2001;98:8419-24.
  • Xue Y, Zhao Z, Pei J, Wang C, Ding K, Cheng X. Expression and characterization of the dermonecrotic toxin gene of Bordetella bronchiseptica. Sheng Wu Gong Cheng Xue Bao 2011;27:1722-8.
  • Xu Y, Wang Y, Tan Y, Zhang H, Wu L, Wang L, et al. Production and characterization of recombinant pertactin, fimbriae 2 and fimbriae 3 from Bordetella pertussis. BMC Microbiol 2009;9:274.
  • Wu Y, Wu Y, Tefsen B, Shi Y, Gao GF. Bat-derived influenza-like viruses H17N10 and H18N11. Trends Microbiol 2014;22:183-91.
  • World Health Organization. A Description of the process of seasonal and H5N1 influenza vaccine virus selection and development. 19 Nov 2007. Available from: http://www.who.int/gb/pip/pdf_files/Fluvaccvirusselection.pdf World Health Organization. Immunization, Vaccines and Biologicals: Pertussis. 21 Jun 2011. Available from: http://www.who.int/immunization/topics/pertussis/en/
  • Wolf YI, Viboud C, Holmes EC, Koonin EV, Lipman DJ. Long intervals of stasis punctuated by bursts of positive selection in the seasonal evolution of influenza A virus. Biol Direct 2006;1:34.
  • Willems R, Paul A, van der Heide HG, ter Avest AR, Mooi FR. Fimbrial phase variation in Bordetella pertussis : a novel mechanism for transcriptional regulation. EMBO J 1990;9:2803-9.
  • Weinfurter JT, Brunner K, Capuano SV, Li C, Broman KW, Kawaoka Y, et al. Cross-reactive T cells are involved in rapid clearance of 2009 pandemic H1N1 influenza virus in nonhuman primates. PLoS Pathog 2011; 7:e1002381.
  • Walker JM The Protein Protocols Handbook. 2nd ed New York:2002.
  • Vincart B, De Mendon a R, Rottiers S, Vermeulen F, Struelens MJ, Denis O.A specific real-time PCR assay for the detection of Bordetella pertussis. J Med Microbiol 2007;56:918-20.
  • Vidor E, Plotkin SA. Immunogenicity of a two-component (PT & FHA) acellular pertussis vaccine in various combinations. Hum Vaccin 2008 ;4:328-40.
  • Vandebriel RJ, Hellwig SM, Vermeulen JP, Hoekman JH, Dormans JA, Roholl PJ, et al. Association of Bordetella pertussis with host immune cells in the mouse lung. Microb Pathog 2003;35:19-29.
  • Tiwari T, Murphy TV, Moran J. Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis: 2005 CDC Guidelines. 2005. MMWR Recomm Rep 2005;54:1-16.
  • Takada A, Matsushita S, Ninomiya A, Kawaoka Y, Kida H. Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice. Vaccine 2003;21:3212-8.
  • Sveger T, Br ms M, Arborelius M Jr. Pulmonary abnormalities in symptom-free adolescents after infantile pertussis with pneumonia. N Engl J Med 1984;310:390-1.
  • Storsaeter J, Hallander HO, Gustafsson L, Olin P. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 1998;16:1907-16.
  • Stevenson A, Roberts M. Use of Bordetella bronchiseptica and Bordetella pertussis as live vaccines and vectors for heterologous antigens. FEMS Immunol Med Microbiol 2003;37:121-8.
  • Stainer DW, Scholte MJ. A simple chemically defined medium for the production of phase I Bordetella pertussis. J Gen Microbiol 1971;63:211-20.
  • Song L. It is Unlikely That Influenza Viruses Will Cause a Pandemic Again Like What Happened in 1918 and 1919. Front Public Health 2014; 2:39.
  • Song L, Nakaar V, Kavita U, Price A, Huleatt J, Tang J, et al. Efficacious recombinant influenza vaccines produced by high yield bacterial expression: a solution to global pandemic and seasonal needs. PLoS One 2008;3:e2257.
  • Smith GR. How RecBCD enzyme and Chi promote DNA break repair and recombination: a molecular biologist's view. Microbiol Mol Biol 2012;76:217-28.
  • Singh M, Lingappan K. Whooping cough: the current scene. Chest 2006 ;130:1547-53.
  • Schutten M, van Baalen C, Zoeteweij P, Fraaij P. The influenza virus: disease, diagnostics, and treatment. MLO Med Lab Obs 2013;45:38-40.
  • Schoepfer R. The pRSET family of T7 promoter expression vectors for Escherichia coli. Gene 1993;124:83-5.
  • Schmittgen TD and Livak KJ. Analyzing real-time PCR data by the comparative CTmethod. Nat protoc 2008;3:1101-8.
  • Schmitt-Groh S, Cherry JD, Heininger U, berall MA, Pineda E, Stehr K. Pertussis in German Adults. Clin Infect Dis 1995;21:860-6.
  • Schiller CB, Seifert FU, Linke-Winnebeck C, Hopfner KP. Structural Studies of DNA End Detection and Resection in Homologous Recombination. Cold Spring Harb Perspect Biol 2014;6:a017962.
  • Sawal M, Cohen M, Irazuzta JE, Kumar R, Kirton C, Brundler MA, et al. Fulminant pertussis: a multi-center study with new insights into the clinico-pathological mechanisms. Pediatr Pulmonol 2009;44:970-80.
  • Sato H. Japanese experience with 60 million doses of acellular pertussis vaccines. Dev Biol Stand 1997;89:327-9.
  • Samji T. Influenza A: understanding the viral life cycle. Yale J Biol Med 2009;82:153-9.
  • Sambrook J, Russell DW. Molecular cloning: A laboratory manual. 3rd ed. New York: Cold Spring Harbor Laboratory Press; 2001.
  • Rodr guez ME, Hellwig SM, P rez Vidakovics ML, Berbers GA, van de Winkel JG. Bordetella pertussis attachment to respiratory epithelial cells can be impaired by fimbriae-specific antibodies. FEMS Immunol Med Microbiol 2006;46:39-47.
  • Rimmelzwaan GF, McElhaney JE. Correlates of protection: novel generations of influenza vaccines. Vaccine 2008;26:D41-4.
  • Riffelmann M, Wirsing von K nig CH, Caro V, Guiso N. Nucleic Acid amplification tests for diagnosis of Bordetella infections. J Clin Microbiol 2005;43:4925-9.
  • Riffelmann M, Thiel K, Schmetz J, Wirsing von Koenig CH. Performance of commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis. J Clin Microbiol 2010;48:4459-63.
  • Riffelmann M, Littmann M, H l e C, Hellenbrand W, Wirsing von K nig CH. Pertussis: not only a disease of childhood. Dtsch Arztebl Int 2008 ;105:623-8.
  • Richards S. Flu blues. Nurs Stand 2005;20:26-7.
  • Riboli B, Pedroni P, Cuzzoni A, Grandi G, de Ferra F. Expression of Bordetella pertussis fimbrial (fim) genes in Bordetella bronchiseptica: fimX is expressed at a low level and vir-regulated. Microb Pathog 1991;10:393-403.
  • Register KB, Nicholson TL, Guthrie JL. Evaluation of specificity of BP3385 for Bordetella pertussis detection. J Clin Microbiol 2010; 48:3334-7.
  • Reddin KM, Crowley-Luke A, Clark SO, Vincent PJ, Gorringe AR, Hudson MJ et al. Bordetella pertussis fimbriae are effective carrier proteins in Neisseria meningitidis serogroup C conjugate vaccines. FEMS Immunol Med Microbiol 2001;31:153-62.
  • Recker M, Pybus OG, Nee S, Gupta S. The generation of influenza outbreaks by a network of host immune responses against a limited set of antigenic types. Proc Natl Acad Sci USA 2007;104:7711-6.
  • Rahman MM, Uyangaa E, Han YW, Kim SB, Kim JH, Choi JY, et al. Oral administration of live attenuated Salmonella enterica serovar Typhimurium expressing chicken interferon-α alleviates clinical signs caused by respiratory infection with avian influenza virus H9N2. Vet Microbiol 2011;154:140-51.
  • R nn PF, Dalby T, Simonsen J, J rgensen CS, Linneberg A, Krogfelt KA. Seroepidemiology of pertussis in a cross-sectional study of an adult general population in Denmark. Epidemiol Infect 2014;142:729-37.
  • Pittman M. Neurotoxicity of Bordetella pertussis. Neurotoxicology 1986;7:53-67. Poolman JT, Hallander HO. Acellular pertussis vaccines and the role of pertactin and fimbriae. Expert Rev Vaccines 2007;6:47-56.
  • Pientong C, Ekalaksananan T, Teeratakulpisarn J, Tanuwattanachai S, Kongyingyoes B, Limwattananon C. Atypical bacterial pathogen infection in children with acute bronchiolitis in northeast Thailand. J Microbiol Immunol Infect 2011;44:95-100.
  • Pica N, Palese P. Toward a universal influenza virus vaccine: prospects and challenges. Annu Rev Med 2013;64:189-202.
  • Patel A, Gray M, Li Y, Kobasa D, Yao X, Kobinger GP. Co-administration of certain DNA vaccine combinations expressing different H5N1 influenza virus antigens can be beneficial or detrimental to immune protection. Vaccine 2012;30:626-36.
  • Parrish CR, Kawaoka Y. The origins of new pandemic viruses: the acquisition of new host ranges by canine parvovirus and influenza A viruses. Annu Rev Microbiol 2005;59:553-86.
  • Palese P, Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, et al. “Orthomyxoviridae” in Fields Virology. 5th ed. Philadelphia: Lippincott Williams and Wilkins; 2007;1647?1689.
  • Ohtsuka M, Kikuchi K, Shundo K, Okada K, Higashide M, Sunakawa K, et al. Improved selective isolation of Bordetella pertussis by use of modified cyclodextrin solid medium. J Clin Microbiol 2009;47:4164-7.
  • Nuolivirta K, Koponen P, He Q, Halkosalo A, Korppi M, Vesikari T, et al. Bordetella pertussis infection is common in nonvaccinated infants admitted for bronchiolitis. Pediatr Infect Dis J 2010;29:1013-5.
  • Nitsch-Osuch A, Korzeniewski K, Kuchar E, Zielonka T, ?yci?ska K, Wardyn K. Epidemiological and immunological reasons for pertussis vaccination in adolescents and adults. Respir Physiol Neurobiol 2013;187:99-103.
  • Neumann G, Noda T, Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 2009;459:931-9.
  • Nelson MI, Holmes EC. The evolution of epidemic influenza. Nat Rev Genet 2007;8:196-205.
  • Nayak DP, Davis AR, McQueen NL, Bos TJ, Jabbar MA, Sivasubramanian N, et al. Biological and immunological properties of haemagglutinin and neuraminidase expressed from cloned cDNAs in prokaryotic and eukaryotic cells. Vaccine 1985;3:165-71.
  • Nayak B, Kumar S, DiNapoli JM, Paldurai A, Perez DR, Collins PL, et al. Contributions of the avian influenza virus HA, NA, and M2 surface proteins to the induction of neutralizing antibodies and protective immunity. J Virol 2010;84:2408-20.
  • Mooi FR, Jansen WH, Brunings H, Gielen H, van der Heide GH, Walvoort HC, et al. Construction and analysis of Bordetella pertussis mutants defective in the production of fimbriae. Microbial Pathogenesis 1992;12:127 ?35.
  • McGuirk P, Mills KH. Direct anti-inflammatory effect of a bacterial virulence factor: IL-10-dependent suppression of IL-12 production by filamentous hemagglutinin from Bordetella pertussis. Eur J Immunol 2000; 30:415-22.
  • McGuiness CB, Hill J, Fonseca E, Hess G, Hitchcock W, Krishnarajah G. The disease burden of pertussis in adults 50 years old and older in the United States: a retrospective study. BMC Infect Dis 2013;13:32.
  • McCullers JA. The co-pathogenesis of influenza viruses with bacteria in the lung. Nat Rev Microbiol 2014;12:252-62.
  • Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005;18:326-82.
  • Marzouqi I, Richmond P, Fry S, Wetherall J, Mukkur T. Development of improved vaccines against whooping cough: current status. Hum Vaccin 2010;6:543-53.
  • Mani I, Singh V, Chaudhary DK, Somvanshi P, Negi MP. Codon optimization of the major antigen encoding genes of diverse strains of influenza a virus. Interdiscip Sci 2011;3:36-42.
  • Mair CM, Ludwig K, Herrmann A, Sieben C. Receptor binding and pH stability - how influenza A virus hemagglutinin affects host-specific virus infection. Biochim Biophys Acta 2014;1838:1153-68.
  • MacIntyre CR, Wang Q, Rahman B, Seale H, Ridda I, Gao Z, et al. Efficacy of face masks and respirators in preventing upper respiratory tract bacterial colonization and co-infection in hospital healthcare workers. Prev Med 2014;62:1-7.
  • Loker SB, Temple LM, Preston A. The Bordetella avium BAV1965-1962 fimbrial locus is regulated by temperature and produces fimbriae involved in adherence to turkey tracheal tissue. Infect Immun 2011;79:2423-9.
  • Locht C, Bertin P, Menozzi FD, Renauld G. The filamentous haemagglutinin, a multifaceted adhesion produced by virulent Bordetella spp. Mol Microbiol 1993;9:653-60.
  • Liu C, Eichelberger MC, Compans RW, Air GM. Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding. J Virol 1995;69:1099-106.
  • Lieberman D, Shvartzman P, Lieberman D, Ben-Yaakov M, Lazarovich Z, Hoffman S, et al. Etiology of respiratory tract infection in adults in a general practice setting. Eur J Clin Microbiol Infect Dis 1998;17:685-9.
  • Li Z, Jansen DL, Finn TM, Halperin SA, Kasina A, O'Connor SP, et al. Identification of Bordetella pertussis infection by shared-primer PCR. J Clin Microbiol 1994;32:783-9.
  • Li R, Lim A, Alonso S. Attenuated Bordetella pertussis BPZE1 as a live vehicle for heterologous vaccine antigen delivery through the nasal route. BioengBugs 2011;2:315-9.
  • Li CK, Rappuoli R, Xu XN. Correlates of protection against influenza infection in humans-on the path to a universal vaccine? Curr Opin Immunol 2013;25:470-6.
  • Leininger E, Bowen S, Renauld-Mong nie G, Rouse JH, Menozzi FD, Locht C, et al. Immunodominant domains present on the Bordetella pertussis vaccine component filamentous hemagglutinin. J Infect Dis 1997 ;175:1423-31.
  • Lapin JH. Immunization against whooping cough. J Pediatr 1946;29:90-4.
  • Lambert LC. Pertussis vaccine trials in the 1990s. Infect Dis 2014;209 :S4-9.
  • Lambert LC, Fauci AS. Influenza vaccines for the future. N Engl J Med 2010;363:2036-44.
  • Kuzminov A. DNA replication meets genetic exchange: chromosomal damage and its repair by homologous recombination. Proc Natl Acad Sci USA 2001;98:8461-8.
  • Kumar S, Wang L, Fan J, Kraft A, Bose ME, Tiwari S, et al. Detection of 11 common viral and bacterial pathogens causing community-acquired pneumonia or sepsis in asymptomatic patients by using a multiplex reverse transcription-PCR assay with manual (enzyme hybridization) or automated (electronic microarray) detection. J Clin Microbiol 2008;46: 3063-72.
  • Kowalczykowski SC, Dixon DA, Eggleston AK, Lauder SD, Rehrauer WM. Biochemistry of homologous recombination in Escherichia coli. Microbiol Rev 1994;58:401-65.
  • Koel BF, Burke DF, Bestebroer TM, van der Vliet S, Zondag GC, Vervaet G, et al. Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution. Science 2013;342:976-9.
  • Knight JB, Huang YY, Halperin SA, Anderson R, Morris A, Macmillan A, et al. Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis. Clin Exp Immunol 2006;144:543-51.
  • Kirchner JT. Tdap vaccine: current indications for adolescent and adult patients in the United States. J Am Osteopath Assoc 2011;111:S7-9.
  • Kinebuchi T, Kagawa W, Enomoto R, Tanaka K, Miyagawa, K, Shibata T, et al. Structural basis for octameric ring formation and DNA interaction of the human homologous-pairing protein DMC1. Mol Cell 2004;14:363-74.
  • Kim TJ, Lee JI. Cloning and expression of genes encoding transferrinbinding protein A and B from Actinobacillus pleuropneumoniae serotype 5. Protein Expr Purif 2006;45:235-40.
  • Kim T, Toan NT, Seo J, Jung B, Lee J, Lee B. Bordetella bronchiseptica aroA mutant as a live vaccine vehicle for heterologous porcine circo virus type2 major capsid protein expression. Vet Microbiol 2009;138:318-24.
  • Khafri A, Aghaiypour K, Peerayeh SN, Ghorbani R. Cloning and Expression of S1 Subunit of Pertussis Toxin in Escherichia coli. Avicenna J Med Biotechnol 2011;3:19-24.
  • Kawaoka Y, Webster RG. Sequence requirements for cleavage activation of influenza virus hemagglutinin expressed in mammalian cells. Proc Natl Acad Sci USA 1988;85:324-8.
  • Kammoun H, Roux X, Raze D, Debrie AS, Filette MD, Ysenbaert T, et al. Immunogenicity of Live attenuated B. pertussis BPZE1 producing the universal influenza vaccine candidate M2e. PLoS One 2013;8:e59198.
  • Irons LI, Ashworth LA, Robinson A. Release and purification of fimbriae from Bordetella pertussis. Dev Biol Stand 1985;61:153-63.
  • Irie Y, Matto S, Yuk MH. The Bvg virulence control system regulates biofilm formation in Bordetella bronchiseptica. J Bcteriol 2004;186:5692-8.
  • International Committee on Taxonomy of Viruses (ICTV). Index of Viruses In: ICTVdB - Orthomyxovirus (2013). Available from: http://ictvonline.org/virusTaxonomy.asp
  • Huygen K, Rodeghiero C, Govaerts D, Leroux-Roels I, Melin P, Reynders M, et al. Bordetella pertussis seroprevalence in Belgian adults aged 20-39 years, 2012. Epidemiol Infect 2014;142:724-8.
  • Hui DS. Review of clinical symptoms and spectrum in humans with influenza A/H5N1 infection. Respirology 2008;S1:10-3.
  • Hosoya N, Miyagawa K. Targeting DNA damage response in cancer therapy. Cancer Sci 2014;105:370-88.
  • Hoffmann E, Stech J, Guan Y, Webster RG, Perez DR. Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol 2001;146:2275-89.
  • Hendrich H. The laboratory Mouse: Handbook of experimental animals. 2nd ed. Oxford: Academic Press; 2012.
  • Heininger U, Stehr K, Schmitt-Grohe S, Lorenz C, Rost R, Christenson PD, et al. Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussis. Pediatr Infect Dis J 1994;13:306-9.
  • Heininger U, Cherry JD. Pertussis immunisation in adolescents and adults-Bordetella pertussis epidemiology should guide vaccination recommendations. Expert Opin Biol Ther 2006;6:685-97.
  • Hatta M, Kawaoka Y. Clue to the molecular mechanism of virulence of highly pathogenic H5N1 avian influenza viruses isolated in 2004. Uirusu 2005;55:55-61.
  • Halperin SA. Developing better paediatric vaccines: the case of pertussis vaccine. BioDrugs 1999;12:175-91.
  • Halperin SA, Bortolussi R, Langley JM, Miller B, Eastwood BJ. Seven days of erythromycin estolate is as effective as fourteen days for the treatment of Bordetella pertussis infections. Pediatrics 1997;100:65-71.
  • Hallander HO, Ljungman M, Jahnmatz M, Storsaeter J, Nilsson L, Gustafsson L. Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim 2/3 antibodies after vaccination and infection. APMIS 2009;117:660-71.
  • Guthrie JL, Robertson AV, Tang P, Jamieson F, Drews SJ. Novel duplex real-time PCR assay detects Bordetella holmesii in specimens from patients with Pertussis-like symptoms in Ontario, Canada. J Clin Microbiol. 2010;48:1435-7.
  • Guiso N. Bordetella pertussis: Why is it still circulating? Infection 2014;68:S119-24.
  • Guiso N, Berbers G, Fry NK, He Q, Riffelmann M, Wirsing von K nig CH. What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. Eur J Clin Microbiol Infect Dis 2011;30:307-12.
  • Grohskopf LA, Olsen SJ, Sokolow LZ, Bresee JS, Cox NJ, Broder KR, et al. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP) - United States, 2014 15 Influenza Season. ? Am J Transplant 2014;14:2906-13.
  • Geuijen CA, Willems RJ, Bongaerts M, Top J, Gielen H, Mooi FR. Role of the Bordetella pertussis minor fimbrial subunit, FimD, in colonization of the mouse respiratory tract. Infect Immun 1997;65:4222-8.
  • Furuya Y, Regner M, Lobigs M, Koskinen A, M llbacher A, Alsharifi M. Effect of inactivation method on the cross-protective immunity induced by whole 'killed' influenza A viruses and commercial vaccine preparations. J Gen Virol 2010;91:1450-60.
  • Fukushi M, Ito T, Oka T, Kitazawa T, Miyoshi-Akiyama T, Kirikae T, et al. Serial histopathological examination of the lungs of mice infected with influenza A virus PR8 strain. PLoS One 2011;6:e21207.
  • Fujiyoshi Y, Kume NP, Sakata K, Sato SB. Fine structure of influenza A virus observed by electron cryo-microscopy. EMBO J 1994;13:318-26.
  • Freymuth F, Vabret A, Brouard J, Toutain F, Verdon R, Petitjean J, et al. Detection of viral, Chlamydia pneumoniae and Mycoplasma pneumoniae infections in exacerbations of asthma in children. J Clin Virol 1999;13:131-9.
  • Frey A, Di Canzio J, Zurakowski D. A statistically defined endpoint titer determination method for immunoassays. J Immunol Methods 1998;221:35-41.
  • Fransen F, Stenger RM, Poelen MC, van Dijken HH, Kuipers B, Boog CJ, et al. Differential effect of TLR2 and TLR4 on the immune response after immunization with a vaccine against Neisseria meningitidis or Bordetella pertussis. PLoS One 2010;5:e15692.
  • Forsdyke DR. Implications of HIV RNA structure for recombination, speciation, and the neutralism-selectionism controversy. Microbes Infect 2014;16:96-103.
  • Fedele G, Bianco M, Ausiello CM. The virulence factors of Bordetella pertussis: Talented modulators of host immune response. Arch Immunol Ther Exp 2013;61:445-57.
  • Fadugba OO, Wang L, Chen Q, Halasa NB. Immune Responses to Pertussis Antigens in Infants and Toddlers after Immunization with Multicomponent Acellular Pertussis Vaccine. Clin Vaccine Immunol 2014;21:1613-9
  • Edwards JA, Groathouse NA, Boitano S. Bordetella bronchiseptica adherence to cilia is mediated by multiple adhesin factors and blocked by surfactant protein A. Infect Immun 2005;73:3618-26.
  • Dixit R, Khandaker G, Ilgoutz S, Rashid H, Booy R. Emergence of oseltamivir resistance: control and management of influenza before, during and after the pandemic. Infect Disord Drug Targets 2013;13:34-45.
  • Di Tommaso A, Domenighini M, Bugnoli M, Tagliabue A, Rappuoli R, De Magistris MT. Identification of subregions of Bordetella pertussis filamentous hemagglutinin that stimulate human T-cell responses. Infect Immun 1991;59:3313-5.
  • Decker KB, James TD, Stibitz S, Hinton DM. The Bordetella pertussis model of exquisite gene control by the global transcription factor BvgA. Microbiol 2012;158:1665-76.
  • Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA 2000;97:6640-5.
  • Czepiel J, Biesiada G, Mach T. Pertussis in adult patients. Pol Merkur Lekarski 2005;19:727-9.
  • Crowcroft NS, Stein C, Duclos P, Birmingham M. How best to estimate the global burden of pertussis? Lancet Infect Dis 2003;3:413-8.
  • Connell TG, Shey MS, Seldon R, Rangaka MX, van Cutsem G, Simsova M, et al. Enhanced ex vivo stimulation of Mycobacterium tuberculosis-specific T cells in human immunodeficiency virus-infected persons via antigen delivery by the Bordetella pertussis adenylate cyclase vector. Clin Vaccine Immunol 2007;14:847-54.
  • Cloud JL, Hymas W, Carroll KC. Impact of nasopharyngeal swab types on detection of Bordetella pertussis by PCR and culture. J Clin Microbiol 2002;40:3838-40.
  • Clark NM, Lynch JP. Influenza: epidemiology, clinical features, therapy, and prevention. Semin Respir Crit Care Med 2011;32:373-92.
  • Cherry JD. Pertussis in the preantibiotic and prevaccine era, with emphasis on adult pertussis. Clin Infect Dis 1999;S2:S107-11.
  • Cherry JD. Adult pertussis in the pre-and post-vaccine eras: lifelong vaccine-induced immunity? Expert Rev Vaccines 2014;13:1073-80.
  • Cherry JD, Heininger U, Richards DM, Storsaeter J, Gustafsson L, Ljungman M, et al. Antibody response patterns to Bordetella pertussis antigens in vaccinated (primed) and unvaccinated (unprimed) young children with pertussis. Clin Vaccine Immunol 2010;17:741-7.
  • Cherry JD, Gornbein J, Heininger U, Stehr K. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine 1998;16:1901-6.
  • Chen Z, Yoshikawa T, Kadowaki S, Haqiwara Y, Matsuo K, Asanuma H, et al. Protection and antibody responses in different strains of mouse immunized with plasmid DNAs encoding influenza virus haemagglutinin, neuraminidase and nucleoprotein. J Gen Virol 1999;80:2559-64.
  • Chen Q, Decker KB, Boucher PE, Hinton D, Stibitz S. Novel architectural features of Bordetella pertussis fimbrial subunit promoters and their activation by the global virulence regulator BvgA. Molecular Microbiol 2010;77:1326-340.
  • Centers for Disease Control and Prevention. vaccination. Pertussis Cases by Year (1922-2013). Updated 27, August 2014. Avilable from: http://www.cdc.gov/pertussis/surv-reporting/cases-by-year.html
  • Centers for Disease Control and Prevention. Pertussis (whooping cough). Updated 22, May 2014. Avilable from: http://www.cdc.gov/pertussis/ about/signs-symoms.html
  • Centers for Disease Control and Prevention. Flublok seasonal influenza (flu) vaccination. 2014. Avilable from: http://www.ema.europa.eu/docs/en _GB/document_library/EPAR_-_Summary_for_the_public/human/001101/WC5 00103712.pdf
  • Centers for Disease Control and Prevention. Clinical Signs and Symptoms of Influenza. Updated 1, July 2009. Avilable from: http://www.cdc.gov/flu /professionals/acip/clinical.htm
  • Cauldwell AV, Long JS, Moncorg O, Barclay WS. Viral determinants of influenza A virus host range. J Gen Virol 2014;95(Pt 6):1193-210.
  • Call SA, Vollenweider MA, Hornung CA, Simel DL, McKinney WP. Does this patient have influenza? JAMA 2005;293:987-97.
  • Bouvier NM, Palese P. The biology of influenza viruses. Vaccine 2008;26 S4:D49-53.
  • Bouabe H, Okkenhaug K. Gene targeting in mice: a review. Methods Mol Biol 2013;1064:315-36.
  • Bordet J, Gengou O. Le microbe de la coqueluche, Ann Inst Pasteur 1906;20:731-41.
  • Bonhoeffer J, B r G, Riffelmann M, Sol r M, Heininger U. The Role of Bordetella Infections in Patients with Acute Exacerbation of Chronic Bronchitis. Infection 2005;33:13-7.
  • Biggerstaff M, Cauchemez S, Reed C, Gambhir M, Finelli L. Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: a systematic review of the literature. BMC Infect Dis 2014;14:480.
  • Bezerra PG, Britto MC, Correia JB, Duarte Mdo C, Fonceca AM, Rose K, et al. Viral and atypical bacterial detection in acute respiratory infection in children under five years. PLoS One 2011;6:e18928.
  • Beyer WE, McElhaney J, Smith DJ, Monto AS, Nguyen-Van-Tam JS, Osterhaus AD. Cochrane re-arranged: support for policies to vaccinate elderly people against influenza. Vaccine 2013;31:6030-3.
  • Bernstein C, Bernstein H. DNA Repair in Bacteriophage. In: Nickoloff JA, Hoekstra MF(Eds.) DNA Damage and Repair, 3. Advances from phage to humans 2001. Human press, Totowa, NJ. 1-19.
  • Bell CE. Structure and mechanism of Escherichia coli RecA ATPase. Mol Microbiol 2005;58:358-66.
  • Beaver ME, Karow CM. Incidence of seropositivity to bordetella pertussis and mycoplasma pneumoniae infection in patients with chronic laryngotracheitis. Laryngoscope 2009;119:1839-43.
  • Bayne AC, Boltz D, Owen C, Betz Y, Maia G, Azadi P, et al. Vaccination against influenza with recombinant hemagglutinin expressed by Schizochytrium sp. confers protective immunity. PLoS ONE 2013;8:e61790.
  • Ayala VI, Teijaro JR, Farber DL, Dorsey SG, Carbonetti NH. Bordetella pertussis infection exacerbates influenza virus infection through pertussis toxin-mediated suppression of innate immunity. PLoS ONE 2011;6:e19016.
  • Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, et al. Short protocols in Molecular Biology. 5th ed. New York: John. Wiley and Sons; 2002.
  • Andr P, Caro V, Njamkepo E, Wendelboe AM, Van Rie A, Guiso N. Comparison of serological and real-time PCR assays to diagnose Bordetella pertussis infection in 2007. J Clin Microbiol 2008;46:1672-7.
  • Alexander F, Matheson M, Fry NK, Labram B, Gorringe AR. Antibody responses to individual Bordetella pertussis fimbrial antigen Fim 2 or Fim 3 following immunization with the five-component acellular pertussis vaccine or to Pertussis disease. Clin Vacc Immunol 2012;19:1776-83.
  • Alejska M, Kurzy?ska-Kokorniak A, Broda M, Kierzek R, Figlerowicz M. How RNA viruses exchange their genetic material. Acta Biochim Pol 2001;48:391-407.
  • ?Albrecht T, Almond JW, Alfa MJ, Alton GG, Aly R, Asher DM et al. Bordetella chapter in Medical Microbiology. 4th ed. Texas: Baron S; 1996 (online text at the NCBI bookshelf).